April 13, 2015
VAXIN NAMES ELIZABETH ADKINS CZEREPAK AS CHIEF FINANCIAL OFFICER
Media
April 08, 2015
Cortendo AB Joins National Organization for Rare Disorders (NORD)® Corporate Council
March 26, 2015
Oversubscribed Initial Public Offering on Euronext Paris for HealthCap portfolio company Cerenis Therapeutics
March 25, 2015
Nexstim Plc Announces Changes to its Board of Directors
March 23, 2015
Cortendo AB Announces Appointments of A. Brian Davis as Chief Financial Officer and Stephen Long as Chief Legal Officer
March 23, 2015
Oncopeptides Receives EMA and FDA Orphan Drug Designation for Melflufen in the Treatment of Multiple Myeloma
March 20, 2015
BOOKBUILDING SUCCESSFULLY COMPLETED – OFFER SHARES PRICED AT NOK 32 PER SHARE RAISING NOK 500 MILLION IN GROSS PROCEEDS
March 18, 2015
Cortendo AB Names John H. Johnson as Chairman and Appoints Richard Kollender as Director
March 17, 2015
VAXIN CEO TO PRESENT AT FUTURE LEADERS IN THE BIOTECH INDUSTRY CONFERENCE
March 17, 2015
NORDIC NANOVECTOR – INCREASE IN OFFERING SIZE AND NARROWING OF THE INDICATIVE PRICE RANGE